CD33 CAR T-Cells (CD33CART) for Children and Young Adults with Relapsed/Refractory AML: Dose-Escalation Results from a Phase I/II Multicenter TrialNirali N. Shah, Richard Aplenc, Sarah K. Tasian et al.|Blood|2023Cited by 62
Composite GRFS and CRFS Outcomes After Adult Alternative Donor HCTRohtesh S. Mehta, Baldeep Wirk, Shernan G. Holtan et al.|Journal of Clinical Oncology|2020Cited by 50
Anicteric veno-occlusive disease after hematopoietic stem cell transplantation in childrenJeffrey Naples, Rajinder S. Bajwa, Micah Skeens et al.|Bone Marrow Transplantation|2015Cited by 32
Return to Work Among Young Adult Survivors of Allogeneic Hematopoietic Cell Transplantation in the United StatesNeel S. Bhatt, Betty K. Hamilton, Ruta Brazauskas et al.|Transplantation and Cellular Therapy|2021Cited by 25
Treosulfan, Fludarabine, and Low-Dose Total Body Irradiation for Children and Young Adults with Acute Myeloid Leukemia or Myelodysplastic Syndrome Undergoing Allogeneic Hematopoietic Cell Transplantation: Prospective Phase II Trial of the Pediatric Blood and Marrow Transplant ConsortiumEneida R. Nemecek, Colleen Delaney, Ralf A. Hilger et al.|Transplantation and Cellular Therapy|2018Cited by 21